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Abstract 
An age-cohort decomposition applied to panel data identifies how the mean, overall 
inequality and income-related inequality of self-assessed health evolve over the life cycle and 
differ across generations in 11 EU countries. There is a moderate and steady decline in mean 
health until the age of 70 or so and a steep acceleration in the rate of health deterioration 
beyond that age. In southern European countries and in Ireland, which have experienced the 
greatest changes in economic and social development, the average health of younger 
generations is significantly better than that of older generations. This is not observed in the 
northern European countries. In almost all countries, health is more dispersed among older 
generations indicating that Europe has experienced a reduction in overall health inequality 
over time. Although there is no consistent evidence that health inequality increases as a given 
cohort ages, this is true in the three largest countries – Britain, France and Germany. In the 
former two countries and the Netherlands, at least for males, the income gradient in health 
peaks around retirement age, as has been found for the US, but this pattern is not observed in 
the other countries. In most European countries, unlike the US, there is no evidence that 
income-related health inequality is greater among younger than older generations. 
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1 Introduction 
How does the distribution of health evolve over the life cycle and is it changing across 
generations? How do socioeconomic disparities in health change as individuals age and are 
they narrowing, or widening, across generations? These questions are addressed using 
comparable panel data from 11 European countries. The analysis is pertinent not only to 
gauging the consequences of the rapid population ageing occurring in Europe and elsewhere, 
but also to determining the causes of the socioeconomic gradient in health and the extent to 
which European countries have been successful in reducing such disparities over time. 
Knowledge of how the distribution of health changes over the course of the life cycle is key 
to understanding individual behaviour with respect to retirement, saving, health insurance and 
the utilisation of health care, and, consequently, to the formation of public policy concerning 
pensions, health financing, and health and social care. Evidence of generational differences in 
health is essential for accurate monitoring and projection of trends in population health, and 
can signal potential determinants of health, such as living conditions in childhood. 
Beyond a certain age it is anticipated that health will begin to decline. But at what 
age, on average, does this decline set in? What is the rate of decline? And from which age 
does this accelerate such that the deterioration in health becomes rapid? The answers to these 
questions have important implications for a wide range of policies including, for example, 
increases in the retirement age that are being implemented, or considered, in a number of 
European countries. Besides identifying the average rate of change in health across the life 
cycle, it is also important to establish whether health becomes more or less dispersed as a 
cohort of individuals ages. Deaton and Paxson (1998) argue that if shocks to health are 
permanent, then their cumulative effect will result in health being more widely dispersed at 
older ages. In this case, there would be welfare gains from pooling risks across periods to 
provide protection against the cumulative deterioration of health, or at least its financial 
consequences, but these may not be realisable given the enforceable insurance contracts 
currently offered by markets (Diamond, 1992; Cochrane, 1995; Pauly et al., 1995). Divorcing 
health financing contributions from risks, as is done in most European social insurance and 
tax financed systems, may partially solve this problem but relies on within, as well as 
between, generation solidarity that could become increasingly strained as a cohort ages and 
redistribution from the healthy to the unhealthy increases. A further implication if health 
dispersion does indeed increase with age is that ageing of the population would lead to 
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greater total inequality in health, providing there were no offsetting differences across 
generations. 
The existence of socioeconomic inequality in health in Europe and elsewhere is firmly 
established (Adler et al., 1994; van Doorslaer et al., 1997; Mackenbach et al., 1997; Smith, 
1998, 1999; van Doorslaer and Koolman, 2004), but its causes are not yet well understood. 
Examination of how the socioeconomic gradient in health varies across the life cycle can help 
reveal its origins (Case et al., 2002; Smith, 2005a; Currie et al., 2007). For example, there is 
some US evidence of the gradient peaking around retirement age (Elo and Preston, 1996; 
Smith and Kington, 1997; Deaton and Paxson, 1998; Smith, 2005b). This is consistent with 
the gradient in large part reflecting income losses from illness-induced interruptions to work, 
which obviously cease after retirement. While a couple of European studies confirm this 
inverse U-shape in the age profile of the health-income gradient (Van Ourti, 2003; Kamrul 
Islam et al., 2007), others show that it continues to prevail post retirement (Gerdtham and 
Johannesson, 2000; Burström et al., 2005), albeit less so for an occupation based measure of 
socioeconomic status (Marmot and Shipley, 1996), and even to increase in early old age 
(Chandola et al., 2007). This is relevant to an ongoing debate, to which we aim to contribute, 
over whether the relationship between health and socioeconomic status follows a process of 
cumulative advantage, with early life disparities in health becoming magnified over the life 
cycle (Ross and Wu, 1996; Lynch, 2003; Wilson et al., 2007; Kim and Durden, 2007), or 
whether health problems that inevitably arise in the course of time act as a leveller and so 
narrow socioeconomic disparities in old age (Kunst and Mackenbach 1994; Elo and Preston 
1996; Deaton and Paxson 1998; Beckett 2000; Case and Deaton 2005; Herd 2006; Kim and 
Durden, 2007). 
 The distribution of health may differ between generations because of changes in the 
health system, such as the extension of coverage, or advances in medical technology that are 
effective for the treatment of age-specific conditions. Differences in the health, economic and 
social conditions experienced in early childhood are also potentially important contributors to 
inter-generational differences in health. There is considerable evidence supporting a strong 
link between early childhood, even intrauterine, experiences and health in later life (Barker, 
1995; Case et al., 2005; van den Berg et al., 2006; Bozzoli et al., 2007). The socioeconomic 
gradient in health may differ across generations in response to changes in wider social and 
economic disparities (Pappas et al., 1993; Preston and Elo, 1995; Deaton and Paxson, 1998). 
These cohort effects potentially confound age effects, but they are also of interest in their 
own right. Not least for the purpose of predicting the consequences of population ageing, one 
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wants to know whether younger generations are, on average, healthier than older generations, 
whether health inequality is increasing or decreasing, and whether the socioeconomic 
gradient in health is becoming more or less steep over time. 
 In this paper we describe how the distribution of health and income-related health 
inequality evolve over the life cycle and differ across generations in 11 European Union (EU) 
countries. This is the first study to disentangle age and cohort effects for the mean level of 
self-assessed health, as well as for overall and income-related health inequality, across a large 
number of European countries. It enables us to establish whether the life cycle evolution of 
health and its socioeconomic gradient are consistent across countries. Any observed 
differences in the age profiles may reflect differences in welfare systems and their 
consequences for the way in which age, health and income interact. The 11 countries studied 
span the north and south of Europe and so differ in the scale and timing of the economic and 
social development, as well as changes in public health and nutrition conditions, experienced 
over the lives of the adults represented in the data. We examine whether this heterogeneity is 
reflected in the size and nature of generational differences in the distribution of health. 
The analysis is closely related to that of Deaton and Paxson (1998), who describe how 
average self reported health, its variance and its correlation with income vary with age in US 
cohorts. They find that average health declines with age at a surprisingly constant rate. This 
finding is confirmed for Britain by Sutton (2004) and for Sweden by Burström et al. (2005). 
The US and European studies are less consistent with respect to the direction of the cohort 
effect. Deaton and Paxson (1998) find that average health is lower for older cohorts but there 
is no difference between cohorts born after 1945, while Sutton (2004) and Burström et al. 
(2005) find that younger cohorts report lower health.  
Deaton and Paxson (1998) find that the variance in health is increasing up to the age 
of 60, after which it remains constant. This is only partially consistent with their prediction 
that, if health shocks are permanent and not perfectly correlated across individuals, then the 
variance should be monotonically rising with age for a fixed cohort of individuals. The 
incomplete empirical verification may be due to selective mortality but it could also indicate 
invalidity of the assumptions made about the evolution of health. Deaton and Paxson assume 
that health shocks are additive and independent, and so health follows a random walk. If 
instead one assumes multiplicative shocks deriving from the depreciation of health capital 
(Grossman, 1972), then the prediction of increasing variance with age no longer holds.1 We 
add to Deaton and Paxson’s previously sole analysis of the relationship between age and the 
variance of health with the purpose of improving understanding of how health evolves over 
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the life cycle. We also seek to establish whether Deaton and Paxson’s finding of a smaller 
variance among later born cohorts, indicating that the distribution of health in the US is 
becoming more compressed, is confirmed for European countries. 
Deaton and Paxson (1998) find that the income gradient in health is greater among 
younger cohorts in the US, such that socioeconomic inequality in health has been rising while 
total health inequality, measured by the variance, has been falling. Kamrul Islam et al. (2007) 
find that socioeconomic inequalities in reported health have been increasing over time in 
Sweden, but Ferrie et al. (2002) and Burström et al. (2005) find little or no evidence of 
increasing socioeconomic inequality in morbidity in the UK and Sweden respectively.2 We 
substantially extend the evidence on how socioeconomic inequality in health is changing 
across Europe through analysis of common measures of health and income from 11 EU 
countries. 
The remainder of this paper is organized as follows. Section 2 describes the data and 
the measurement of health using utility scores to scale self-reported health categories. This 
procedure avoids the assumption, made by Deaton and Paxson (1998), that health declines 
linearly across categories and results in a more plausible age profile of health. The 
implications for the measurement of health inequality are also discussed here. Section 3 
presents the methodology for separating age from cohort effects using the panel data. In 
section 4 we present the results and in section 5 their robustness is checked to different 
aspects of the methodology. In the final section we summarise the results and discuss their 
implications. 
 
2 Data and measurement of health 
We use data taken from the full eight waves (1994-2001) of the European Community 
Household Panel (ECHP). The ECHP was designed and coordinated by the European 
Statistical Office (EUROSTAT). It consists of a panel of households providing data on 
socioeconomic, demographic and health characteristics of individuals aged 16 or older. We 
restrict attention to adults aged 18 and above. The questionnaire is standardized across all 
countries. We use all waves that are available for 11 EU member states: Belgium, Denmark, 
France, Germany, Greece, Ireland, Italy, the Netherlands, Portugal, Spain and the United 
Kingdom. Luxembourg is not included due the small size of the sample and Austria, Finland 
and Sweden are not analyzed due to the limited number of available waves (respectively 7, 6 
and 5). For Germany and the UK, we do not use the original ECHP samples (which only ran 
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for the first three waves) but instead use the corresponding waves from the German Socio-
economic Panel (GSOEP) and the British Household Panel Survey (BHPS).3 One wave (9) of 
the BHPS is dropped because of an inconsistency in the health question (Hernández-Quevedo 
et al., 2007) and the 2002 wave (12) is added as a replacement. As a result, we analyse 
exactly eight waves for all countries. Table A.1 in the appendix lists the sample sizes and 
some descriptive statistics from the data. All analyses are conducted separately for each of 
the 11 countries. 
The two key variables in the analysis are health and income. The ECHP income 
measure is annual disposable (i.e. after-tax) household income, including income from work, 
investments, property, private transfers, pensions and other direct social transfers. Indirect 
social transfers (e.g. reimbursement of medical expenses), in kind benefits and imputed rent 
from owner-occupied accommodation are not included. Income is divided by the OECD 
modified equivalence scale in order to account for differences in household size and 
composition.4 In the BHPS an additional file is used to derive the annual disposable income 
(Bardasi et al., 2007). Concerns about the appropriateness of disposable income as an 
indicator of the living standards of the elderly (see e.g. Van Ourti, 2003; Fahey et al., 2004) 
are less worrisome here as it is only used to rank individuals within cohorts/generations. 
Information on health is from the question, “How is your health in general?” with a five-
point response scale ranging from very good to very bad. A potentially important difference 
in the UK is that the BHPS question instructs respondents to rate their health relative to 
others of the same age.5 This self-assessed health (SAH) variable is widely used and is known 
to be a very good predictor of other health outcomes including mortality (see e.g. Idler and 
Benyamini, 1997). One important drawback is that it is ordinal and so computing descriptive 
statistics directly from it, using a scale of 1 to 5 for example, implicitly assumes movements 
between subsequent SAH categories always represent the same change in health. This is a 
strong assumption. It has been shown that the profile across SAH categories of other self-
reported cardinal measures of general health is concave with the health difference between 
very good and good SAH being smaller than that between good and fair (see Van Doorslaer 
and Jones, 2003). 
To allow for such concavity we transform the ordinal SAH information onto a cardinal 
scale. Utility scores for the SAH categories are taken from the 2001 Canadian Community 
Household Survey (CCHS), which is a large scale household survey that contains data on 
both the five-point SAH question available in the ECHP and a general health measure with a 
cardinal scaling—the Health Utility Index Mark 3 (HUI3) (Furlong et al., 2001; Feeny et al., 
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2002). The HUI3 uses a multi-attribute function to transform an individual’s health status 
measured on eight domains into a utility score derived from community preferences over 
health states (Furlong et al., 2001; Feeny et al., 2002). The index has interval scale properties 
and is scaled such that a value of 0 represents death and 1 indicates perfect health. We attach 
the SAH category specific means of HUI3 computed from the Canadian sample to the 
respective SAH categories in the ECHP data. Obviously this is somewhat restrictive in that it 
does not allow for any differences between the EU countries and Canada in the profile of 
mean health utility across SAH categories. But this is no more restrictive than imposing the 
same arbitrary scale on SAH categories across all countries and there is no information 
available that would allow the scale to differ across countries. Moreover, a multi-attribute 
utility function estimated from French data proved to be very similar to the original function 
estimated from the Canadian data (Le Galès et al., 2002). 
The interval scale property of the HUI3 has consequences for the summary statistics 
used to measure overall and income-related health inequality. The concentration index has 
been a popular measure of income-related health inequalities (Wagstaff et al., 1991; van 
Doorslaer et al., 1997), but in a recent contribution Erreygers (2006) has shown that its 
validity crucially depends upon the scaling of the underlying health variable. If the scaling is 
interval (as is the case for the HUI3), the concentration index will have the following 
undesirable properties: (i) its bounds will depend on the minimum, maximum and average 
value of health, (ii) its value will differ depending upon whether health (HUI3) or ill-health 
(i.e. one minus HUI3) is examined, and (iii) its value will not be invariant to a positive linear 
transformation. These properties may obscure the life cycle profile and generational 
differences in income-related health inequality. For example, the first property implies that 
the life cycle profile of average health will influence the life cycle profile of the concentration 
index; and the third property implies that changing the location of the HUI3, which is 
essentially arbitrary, may change the generational differences in the concentration index. 
Using an axiomatic approach, Erreygers (2006) derives an adjusted concentration index that 
does not have these drawbacks, but preserves other desirable properties of the concentration 
index as a measure of income-related health inequality.6 A similar argument holds for 
measures of total health inequality. For example, the variance, the coefficient of variation and 
the Gini index all require that the underlying health variable has ratio scale properties. 
Application of one of these three measures to the interval scaled HUI3 leads to the same three 
undesirable properties. Erreygers (2008) develops an adjusted Gini index that does not have 
these deficiencies. It is similar to the adjusted concentration index, except that individuals are 
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ranked by health, rather than income. The issue does not arise for mean health. Although 
mean health is only uniquely defined up to a positive linear transformation of the interval 
scaled HUI3, its life cycle profile is not affected. The latter follows from the fact that the 
mean of a positive linear transformed variable equals the positive linear transformation of the 
mean, which is not the case for the traditional measures of total and income-related health 
inequalities.7 
For a given SAH category, older individuals tend to have lower health as measured by 
HUI3 (Lindeboom and van Doorslaer, 2004). It is likely that this reflects both the inability of 
a crude ordinal measure such as SAH to capture all the variation in health and age differences 
in the thresholds of true health at which health is reported to be very poor, poor, etc (ibid). To 
allow for variation in HUI3 by age and sex within SAH category, and so simultaneously 
correct for age-sex heterogeneity in reported SAH, we assign the SAH category, age-sex 
specific means of HUI3 from the Canadian data to ECHP observations within the respective 
SAH category. Figure 1 illustrates, using the CCHS data for males, the impact on age profiles 
of applying age-sex specific HUI3 scores to the SAH categories. Profiles are presented for 
the measures of health’s central tendency (mean), total inequality (adjusted Gini) and 
income-related inequality (adjusted concentration index).8 For each statistic, the age profile is 
presented for SAH categories scaled using: (i) 1 (very bad) to 5 (very good), as in Deaton and 
Paxson (1998), (ii) category means of HUI3, (iii) category and age-sex specific means of 
HUI3. A fourth graph for each statistic shows the profile using the actual HUI3 score for each 
observation. 
Using the simple 1-5 scaling of SAH, the profile shows a rather implausible near 
linear decrease in mean health with age. This is similar to what was found by Deaton and 
Paxson (1998). Using the SAH category specific HUI3 scores has little impact on the profile 
for mean health but when age-sex specific scores within each SAH category are used the 
profile displays greater concavity indicating, as seems plausible, that mean health declines 
more rapidly at older, than at younger, ages.9 We conclude that SAH alone is too crude a 
measure to capture the age profile of mean health but scaling it by age-sex specific utility 
scores yields plausible results. For the adjusted Gini, moving from the 1-5 scaling of SAH to 
age-sex specific utility scores within each SAH category brings the age profile closer to that 
obtained from the observation specific utility scores. But, of course, the magnitude of the 
dispersion can never reach that obtained from the individual specific scores. At any given 
age, the adjusted Gini using the age-specific HUI3 scores is about three times smaller than 
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that obtained from the actual scores. The age profile of the adjusted concentration index is 
less sensitive to the method of scaling SAH. 
 
[insert Figure 1 about here] 
 
3 Decomposition of age and cohort effects 
The longitudinal nature of the ECHP makes it possible to perform a true cohort analysis. 
Following the same individuals over time identifies the age effect by observing how their 
health changes as they age. In order to identify the cohort effect, we group observations by 
birth year intervals and compare, for example, mean health of two cohort groups at the same 
age across different waves. This is done through cohort level regression analysis, as in 
Deaton and Paxson (1998). This avoids the imposition of any restrictions on the nature of the 
age and cohort effects at the individual level, which would be unavoidable if the regression 
analysis were conducted at that level. 
Although, ideally, one would construct a cohort specific to each birth year, this would 
result in too few observations per cohort in each wave. Instead, we construct 13 cohorts of 
five-year birth intervals. Since there are very few observations in the oldest cohorts we 
exclude individuals born before 1912. It follows that the youngest cohort was born within the 
period 1972-1976, with an average age of 20 in the first wave and ages on average to 27 in 
the last wave. The oldest cohort was born between 1912 and 1916, with an average age of 80 
in the first wave and 87 in the last. 
It is the ageing over time within a cohort that identifies the age effect. The cohort effect is 
identified through comparison between consecutive cohorts at three overlapping ages across 
waves. This is illustrated in Table 1. The youngest cohort ages on average from 25 to 27 
during the last three waves of the panel and can be compared with the second cohort that 
covers this average age span over the first three waves. Likewise, the second and third 
cohorts both span the 30-32 age range during the last and first three waves respectively. 
 
[insert Table 1 about here] 
 
We compute each of the three statistics—mean, adjusted Gini index and adjusted 
concentration index—for SAH category, age-sex specific HUI3 scores (hereafter referred to 
as scaled SAH) for each cohort in each wave and estimate both the age and cohort effects by 
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regressing each statistic on a full set of age and cohort dummies. Because it is likely that 
health dynamics differ across sexes, all analyses are performed separately for males and 
females. These regressions are based on 104 observations, i.e. 8 waves times 13 cohorts. We 
use a separate dummy for each cohort, but the construction of the age dummies is more 
subtle. We need to ensure that the age range captured by any given age dummy does not span 
more than one cohort defined by a five-year birth interval. Single year age dummies would, 
of course, suffice but leave too few degrees of freedom. Instead, we enter a combination of 
one and two-year age dummies to indicate the average age of each cohort in each wave.10 
Consistent with the cohort nature of the analysis, we use all observations present in 
the first wave (1994).11 The 1994 cross-sections are made representative of the populations in 
that year through application of the ECHP first wave sampling weights (Eurostat, 2003). To 
keep subsequent waves of the unbalanced panel representative of the 1994 populations, and 
so deal with health related attrition that has been found in these data (Jones et al., 2006), we 
construct and apply attrition corrected weights. For all wave 1 observations, we use probit 
regressions to predict the probability of remaining in the sample at each of the subsequent 
waves as a function of the following wave 1 explanatory variables: sex, income, household 
composition, thirteen 5-year age dummies, five SAH dummies and an interaction between 
SAH and age. The wave 1 ECHP provided sampling weights are then multiplied by the 
inverse of these (wave specific) predicted probabilities and, for each wave, this product is 
used to weight each observation in the calculation of the three statistics of interest. These 
statistics are regressed on the set of age and cohort dummies using OLS. 
4 Results 
Before presenting the main results we show how each of the three statistics of interest differ 
by age without disentangling the life cycle and cohort effects. This serves as a point of 
reference against which to gauge the effect of making the age-cohort decomposition. In 
Figure 2, we present for each age group the mean, adjusted Gini index, and adjusted 
concentration index of scaled SAH, separately for males and females. These age profiles 
derive from straightforward regressions with only age dummies.12 The point estimates, 
presented with 95% percent confidence intervals, show differences from the reference 
category of 20-24 years. Intercepts are not shown in the graphs to facilitate cross-country 
comparison of the curvature of the age profiles, and not their levels which are potentially 
more prone to cross-country reporting heterogeneity. Countries are arranged geographically 
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by northern and southern Europe, with Ireland included in the latter group because it bears 
closer resemblance to those countries with respect to the main results presented below. 
For all three statistics, the unadjusted age profiles display a remarkable degree of 
consistency across countries. In most countries, there is little difference in mean health over 
the age range of 20-40, between 40 and 70 there is a steady decrease in health and this 
becomes much steeper above the age of 70. The deterioration of health with age is less steep 
in the UK, the Netherlands, Belgium, Denmark and Ireland than in other countries. For the 
UK, it seems likely that this is due to the different wording of the BHPS SAH question that 
asks respondents to rate their health relative to others of the same age. The adjusted Gini 
index of health seems to increase with age in all countries and the rise is most pronounced at 
higher ages. The increase is shallower in Belgium, Denmark, Ireland, the Netherlands and the 
UK. In most countries, the adjusted concentration index increases with age, reaching its peak 
in the age range in which most people retire (i.e. 55-65) before decreasing. Another striking 
observation from these graphs is that the age profiles for males and females show very little 
difference, especially for the mean and the adjusted Gini index. For the adjusted 
concentration index, gender differences are somewhat larger. For males there is often a clear 
peak around retirement age, while for females the pattern is more gradual, and the peak often 
occurs somewhat earlier. 
 
[insert Figure 2 about here] 
 
In Figure 3, we present the life cycle (light) and cohort (dark) profiles for each of the 
three statistics that derive from the age-cohort regression analysis described in the previous 
section. Again we present coefficients, which show deviations from the reference age (20-24) 
and cohort birth-year (1972-76) groups. For example, when the cohort profile for the mean 
lies below the horizontal at zero, it implies that earlier born cohorts experience worse health 
at any given age. For every country, tests strongly confirm the joint significance of all the age 
dummies and of all the cohort dummies for both the mean and the adjusted Gini index (see 
Appendix Table A.2). For the adjusted concentration index, both the age and the cohort 
dummies are jointly significant, usually at much less than 5%, in every case but for the cohort 
dummies for females in Greece and Spain, and the age dummies for males in Germany. 
For mean health, in general, the life cycle profiles differ little from the unadjusted age 
profiles presented in Figure 2. Health changes little as individuals age between 20 and 40. 
From the age of forty health begins to decline but there is often a levelling, or even an 
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improvement in health between 55 and 65. The flattening of the profile around retirement age 
has been observed in other studies (e.g. Deaton, 2007). Deaton (ibid) conjectures that it could 
result from the pre-retirement group being particularly intolerant to the onset of health 
problems. This may be motivated by the incentives created by disability insurance in the pre-
retirement age range. More optimistically, it could reflect a positive impact of retirement on 
health—a ‘honeymoon phase’ (Atchley, 1976). 
Beyond the 65-70 years age range, health begins to deteriorate rapidly. In a number of 
countries, the degeneration of health appears to be even more compressed into the advanced 
years once control is made for differences in health across generations. Comparison between 
Figures 2 and 3 confirms that this is true for Greece, Ireland, Italy, Portugal and Spain. These 
differences in the age profiles reflect strong cohort effects in these (mostly) southern 
European countries, which are observable in Figure 3. In each of these countries, older 
generations have markedly worse health than their younger counterparts (at a given age). 
Horsman et al. (2003) estimate a difference in HUI3 of 0.05, or more, to represent a clinically 
important change in health. Usually the health difference between the youngest and oldest 
cohort is around 0.1, so this is a substantial improvement in health over generations. Notably, 
four of these countries are southern European and the fifth, Ireland, has also experienced very 
rapid economic and social development over the period spanned by the lives of the adults 
represented in these data. It is conjecture, of course, but it seems plausible that the 
generational differences in health we observe reflect the advances that have been made in 
these countries over the post-war era. In most of the northern European countries (Belgium, 
Denmark, France, Germany and the Netherlands) the cohort effects are jointly significant, but 
there is no evidence of any clear improvement or deterioration in average health across 
generations. In the UK generations born before 1930 for males and 1940 for females actually 
report significantly better health, on average, than more recently born cohorts. This is 
surprising given gains that have been recorded in objective indicators of population health, 
such as life expectancy. It may reflect generational differences in health expectations that 
confound the reporting of health, or it could be an artefact stemming from the reference to 
age in the BHPS SAH question, although one would expect the latter to affect the age profile 
more than the cohort profile. 
With few exceptions, there is an upward gradient in the cohort profile for the adjusted 
Gini index indicating that health is more dispersed among older generations. This is 
consistent with what Deaton and Paxson (1998) found for the US. The tendency towards 
reduced inequality in health among younger generations is strongest in the countries that also 
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show an improvement in average health (Greece, Ireland, Italy, Portugal and Spain). In the 
northern, more industrialized countries, particularly in France, Germany, the Netherlands, the 
compression of the health distribution among younger generations is less pronounced. The 
UK is the only country in which there is less health inequality among older cohorts – 
although only significantly for females – which again might be related to the age reference in 
the SAH question. 
There is less consistency across countries in the life cycle profiles of the adjusted Gini 
index. The tendency for inequality to increase with age that was observed for all countries in 
Figure 2 appears to be driven by the cohort effects. Once these are controlled for there is 
evidence that health becomes significantly more unequally distributed as individuals age only 
for France, Germany, Dutch females and the UK. For these countries the evidence is even 
stronger than that found for the US by Deaton and Paxson (1998) in support of their 
hypothesis that the variability of health increases over the life cycle due the cumulative effect 
of permanent health shocks. But in the remaining countries, the life cycle profile of the 
adjusted Gini index displays a variety of patterns after the age of 50 and is actually 
significantly decreasing with age in Spain and for females in Ireland. There is no emergence 
of a stylised fact that health consistently becomes more unequally distributed as a cohort 
ages. 
 After taking out the cohort effect, the adjusted concentration index continues to show 
some sign of peaking around retirement age only for British, Dutch, French, and Irish males 
and Danish females. But the precision is low, indicated by wide confidence intervals, and the 
profiles could not be described as having a distinct inverted U-shape. In a few cases income-
related health inequality is increasing over the life-cycle (Greek males and Dutch females) 
and in Italy it is falling. In most countries, particularly for females, the cohort profile of the 
adjusted concentration index is flat. Unlike what Deaton and Paxson (1998) found for the US, 
there is little evidence from Europe that the income gradient in health is becoming steeper 
among younger generations. There is evidence that this is occurring only among Dutch 
females. For many of the others, if anything, the trend is in the opposite direction. But it is 
evident that the confidence intervals for the concentration index are often substantially wider 
than those for the other statistics and this might reflect a difficulty in separately identifying 
the age and cohort effects for this statistic. 
 
[insert Figure 3 about here] 
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5 Robustness checks 
In this section we check the robustness of the results to allowing for possible period effects 
and extending the number of waves to better disentangle age from cohort effects. All results 
are available on request from the authors. 
5.1 Allowing period effects 
The regressions underlying Figure 3 do not allow for any period effects. That is, variation in 
health from year-to-year that is common to all ages and cohorts. Period effects are not taken 
into account in the basic analysis for two reasons. First, it seems likely that any common 
year-to-year variation in health over the span of eight years is much less important than age 
and cohort differences. Second, it is well known that unrestricted age, cohort and period 
effects cannot all be separately identified (Weiss and Lillard, 1978) and, even with 
restrictions, it might be overly ambitious to attempt to disentangle all three effects from only 
eight years of data. Yet, period effects on the distribution of health certainly cannot be ruled 
out entirely a priori. They could derive from a business cycle effect operating through labour 
market conditions, levels of stress, consumption of alcohol or accidents (Ruhm 2003 and 
2004). Any changes in disability insurance eligibility rules may also affect the reporting of 
health. It is also possible that innovations in medical technology over the period of the study 
could impact on the distribution of health, although it seems unlikely that our health measure 
is sufficiently sensitive to pick this up. 
Since we are intrinsically interested in the age and cohort effects and we expect the 
period effects, if any, to mainly derive from business cycle fluctuations, it seems most 
appropriate to achieve identification by constraining the period dummies to be orthogonal to 
a linear time trend (Deaton, 1997). This essentially ensures that all trends in the data are 
attributed to the cohort and age effects. The interpretation is now of a fixed age profile, a 
cohort-shift in this profile and period effects stochastically moving the data off the profile. 
Practically, with the orthogonality constraint and restricting the coefficients of the period 
effects to sum to zero, this boils down to estimating the regression with six period dummies, 
defined as in Deaton (1997). 
For most countries and statistics, the period dummies were not significant (especially 
for males).13 In any case, the inclusion of period effects lowered the precision of the estimates 
of the age and cohort effects greatly, while the patterns of the age and cohort profiles 
remained similar. 
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Since our time frame is rather short, making it difficult to separate cycles from a trend, 
we also experimented with year specific macroeconomic indicators—GDP growth and the 
unemployment rate—to capture any business cycle effect. Using Belgium as a test case, the 
regression analyses were repeated with the addition of each of the two macro indicators 
separately and jointly. The addition of GDP growth had a similar impact on the point 
estimates to the inclusion of the restricted period dummies, but without inflating the 
confidence intervals as much. Only for the mean health of females was GDP growth 
significant. Adding the unemployment rate to the regression had a larger impact on the age 
coefficients for all statistics, although it was significant only in the regression of the 
concentration index for females. It appears that this variable is competing with age to pick up 
the over time variation, leading to a distorted age profile. Including both indicators gave 
equivalent results as adding the unemployment rate to the regression.  
Since allowing for period effects, either through dummies or macro indicators, reduces 
the precision of the estimates while leaving the age and cohort profiles much the same, we 
prefer the more parsimonious specification. 
5.2 Extending the number of waves  
All the analyses use eight waves of data taken from the ECHP for most countries and from 
the BHPS and GSOEP in the cases of the UK and Germany. The latter two panels run for 
more than eight waves, providing an opportunity to examine whether eight waves are 
sufficient to adequately identify age and cohort effects. For the UK, we repeated the analysis 
using 13 waves of the BHPS (1991-2004). While with eight waves the cohort effects are 
identified through the comparison of two adjacent cohorts at common ages across waves, 
with 13 waves it is possible to compare three different cohorts at the same age. As 
anticipated, this resulted in more precise estimates of the age and cohort profiles. But the 
shapes of these profiles hardly changed, except for the age profile of the adjusted 
concentration index for males which is no longer significant. This supports our warning at the 
end of section 4 that it appears more difficult to separately identifying the age and cohort 
effects for the adjusted concentrated index. Overall though, our findings suggest that an eight 
year time span is sufficient to identify the patterns of the age and cohort effects. 
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6 Conclusion 
In the context of ageing European populations, it is vital to identify both how the distribution 
of health evolves as individuals age and also how it is changing across generations. 
Revelation of the life-cycle profile of health is crucial to improved understanding of 
individual decisions concerning saving, health insurance and retirement, for example, and 
also to establishing needs for medical and long-term care. A cross-sectional analysis of the 
relationship between health and age does not suffice as this age profile is confounded by 
generational differences in the distribution of health. These cohort effects are not simply a 
nuisance, but tell us how the distribution of health has evolved over decades. Disentangling 
cohort effects from the ‘pure’ age effect is not only important for mean levels of health, but 
also for health inequality, both overall and socioeconomic. If health inequality is increasing 
over the life-cycle, then mechanisms, such as social insurance, that pool risks across periods 
offer welfare gains over sequential, single-period insurance contracts. If part of any 
permanent change in health remains private information, then multi-period contracts offered 
early in life would also face less adverse selection. Of more immediate interest is whether 
European countries have been successful in reducing both total and socioeconomic 
inequalities in health such that, within younger generations, health is less dispersed and less 
closely associated with income than it is among older generations. Finally, examination of 
how income-related health inequality varies across the life cycle can help point to the 
mechanisms that lie behind this gradient.  
Not surprisingly, we find average health to decline with age. More interesting is the 
consistency in the pattern of this decline. In most countries, there is a gradual but steady fall 
in mean health from early adulthood until around the age of 50. The deterioration in health 
generally levels off in middle-age before accelerating rapidly beyond the age of 70. Deaton 
and Paxson (1998) found a less plausible linear decline in health in the US, most probably 
because they did not scale SAH responses to reflect the magnitudes of differences in health 
between categories. The middle-age plateau in the profile of mean health is rather puzzling. It 
may simply be an artefact of the insensitivity of SAH to changes in health in this age range, 
although the use of age-sex specific HUI3 scores within each SAH category makes this less 
likely. The decline in mean health between the ages of 70 and 80 is generally around 0.15 on 
the HUI3 scale, which is substantial given that a change of 0.05 is considered clinically 
significant (Horsman et al., 2003). This rapid deterioration suggests that while health might 
not be a significant physical constraint on raising the retirement age toward 70, currently it 
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would be a substantial constraint beyond that age. Of course, few individuals will wish to 
work until their health makes it physically impossible to continue and so the expected rapid 
decline in health after 70 may encourage individuals to retire well before that age while their 
health still permits them to enjoy their increased leisure time. While these issues are central to 
the debate currently being conducted in many European countries in response to proposals to 
raise the retirement age, we should be careful not to overstep the implications that can be 
drawn from our descriptive analysis. We have identified how health changes on average with 
age but not why it does so. We do not know what role retirement itself plays in determining 
the age at which health begins to decline rapidly. It could well be that a rise in the retirement 
age would shift the age profile of health, although whether it would be most likely to shift 
outward or inward is difficult to establish from the current evidence (Charles, 2002; Shan et 
al., 2005; Neuman, 2007). 
The retirement age is seldom, if ever, increased for the generation currently approaching 
it. Assessment of whether population health is likely to be a constraint on this policy 
therefore requires knowledge of the extent to which the age profile of mean health is shifting 
out for younger generations. Our results indicate that this is happening in southern Europe 
and in Ireland but not in northern Europe. The groupings of countries are consistent with 
anticipated differences in the timing of health benefits from improved nutrition, living 
conditions and access to medical care over the course of the last century and also with 
evidence on cohort differences in adult height across Europe (Garcia and Quintana-Domeque, 
2007). Garcia and Quintana-Domeque find that the same four southern European countries 
that are included in the present study, plus Ireland, experienced increases in mean height 
much later than northern European countries. Bozzoli et al. (2007) confirm this finding and 
demonstrate that the post neonatal mortality rate is negatively and strongly correlated with 
the mean height of a cohort in adulthood. This is consistent with a strong life-long impact of 
health conditions experienced in infanthood (Barker, 1995; Case et al., 2005; Van den Berg 
et al., 2006). It suggests that the gains in adult health for younger generations that are 
observed in the ECHP data for the four southern European countries and Ireland, but not for 
the northern countries, are due to the more marked improvements over the course of the last 
century in the childhood health conditions registered in southern Europe. It is tempting to 
relate this to the later economic development of the five mentioned countries but Bozzoli et 
al. (2007) do not find any role for national income in explaining increases in adult height. 
The absence of any evidence of health gains to younger cohorts in northern European 
countries is perhaps surprising given continuing declines in age-specific mortality rates 
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(Lafortune and Balestat, 2007) but it does not contradict two other European studies that used 
EQ-5D scores to scale SAH in a way that resembles what we did using the HUI3. Sutton 
(2004) actually found reported health to be worse among younger cohorts in the UK. 
Burström et al. (2005) found the same result in Sweden up to the age of 45, but beyond this 
age reported health was better for younger cohorts at any given age. Moreover, Crimmins 
(2004) showed that morbidity and disability show different trends for the elderly and it is 
possible that generational differences in health expectations are obscuring gains in health 
when measured by SAH. There is good evidence from the US of substantial year-on-year 
declines in age specific disability rates (Manton et al., 2007). The evidence on disability 
trends for other OECD countries is less consistent (Lafortune and Balestat, 2007).  
We find a dramatic fall in health inequality over time in all 11 European countries studied 
except France, Germany, the Netherlands and the UK, where it only slightly decreased or 
remained stable. This finding of lower variability in health among younger cohorts is 
consistent with Deaton and Paxson (1998) and implies that both the US and Europe have 
succeeded in decreasing the degree of inequality in population health over the past century. 
But, consistent with other European studies (e.g. Kunst et al., 2005), there is no evidence of 
falling socioeconomic inequality in health across generations. While this may be considered a 
failure, it should be judged alongside the US evidence of increasing socioeconomic inequality 
(Deaton and Paxson, 1998). 
We do not find consistent empirical support for Deaton and Paxson’s (1998) 
hypothesis of rising variability in health over the life-cycle. But the prediction is confirmed 
for the three largest countries—France, Germany and the United Kingdom—and more 
emphatically so than is true for the US (Deaton and Paxson, 1998). These are not the three 
health systems that one would immediately think of as being least likely to provide effective 
health care such that health shocks accumulate and dispersion increases over the life cycle. 
Rather than attempt to reconcile the evidence with the hypothesis, it is perhaps more 
appropriate to reconsider the theory. It may well be that a model of permanent, additive and 
uncorrelated health shocks does not best describe the evolution of health and so cannot 
predict the course of its variability over the life cycle. The issue deserves further study. 
 Without controlling for cohort differences, we confirm US evidence (Elo and Preston, 
1996; Smith and Kington, 1997; Deaton and Paxson, 1998; Smith, 2005b) of an inverse U-
shaped income gradient in health that peaks around the retirement age. But after taking 
account of cohort effects, the inverse U-shape prevails only for British, Dutch, French, and 
Irish males and Danish females. In fact, while the dummies for age and cohort effects are still 
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jointly significant in most countries, for males as well as for females, there is no single 
dominant pattern appearing for the majority of countries. In general, it simply seems much 
harder to disentangle age and cohort effects with sufficient precision for the adjusted 
concentration index than for the mean and adjusted Gini index of SAH. Already the 
confidence intervals for the unadjusted age profiles are larger than for the mean and adjusted 
Gini index, and these become even wider after correcting for cohort effects. 
An important potential limitation of our study is that we identify the cohort effects 
from only three overlapping ages in only two adjacent cohorts. The strong assumption we 
have to impose is that health differences between cohorts at these three ages are 
representative of the differences over the whole life-span. While we have confirmed the 
robustness of our results for the UK using 13, rather than 8, waves, a pseudo-panel approach 
of a long series of cross-sections would provide more identifying information and may allow 
testing of whether the cohort effects merely shift and do not tilt the age profiles. It would, 
however, lose the cross-country dimension of the present study. A second, unavoidable 
limitation is that we can only correct for selective attrition based on observable, and not 
unobservable, characteristics. Despite these limitations, our findings appear relatively robust 
to a number of methodological choices and restrictions imposed by the data. Future work 
should concentrate on whether age and cohort profiles in health differ by socio-demographic 
groups within countries. This would allow consideration not only of how individuals age on 
average, but how the health of certain socioeconomic groups deteriorates relative to that of 
other SES groups (Case and Deaton, 2005). 
 
APPENDIX 
 
[insert Table A.1 about here] 
 
[insert Table A.2 about here] 
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Figure 1: Sensitivity of age profiles to the method of scaling self assessed health (SAH), 
Males, 2001 Canadian Community Household Survey  
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Figure 2: Age differences in mean, adjusted Gini, and adjusted Concentration Index of self assessed health scaled by age-sex specific 
HUI3 scores in 11 EU countries, for males (top) and females (bottom) (1994-2001) 
Belgium [males (top) and females (bottom)] Denmark [males (top) and females (bottom)] 
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France [males (top) and females (bottom)] Germany [males (top) and females (bottom)] 
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The Netherlands [males (top) and females (bottom)] United Kingdom [males (top) and females (bottom)] 
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Greece [males (top) and females (bottom)] Ireland [males (top) and females (bottom)] 
average adj. Gini adj. CI average adj. Gini adj. CI 
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Italy [males (top) and females (bottom)] Portugal [males (top) and females (bottom)] 
average adj. Gini adj. CI average adj. Gini adj. CI 
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Spain [males (top) and females (bottom)]  
average adj. Gini adj. CI    
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Figure 3: Life cycle (light, dotted) and cohort (dark, solid) profiles of mean, adjusted Gini, and adjusted Concentration Index of self-
assessed health scaled by age-sex specific HUI3 scores in 11 EU countries, separately for males (top) and females (bottom) (1994-2001) 
Belgium [males (top) and females (bottom)] Denmark [males (top) and females (bottom)] 
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France [males (top) and females (bottom)] Germany [males (top) and females (bottom)] 
average adj. Gini adj. CI average adj. Gini adj. CI 
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The Netherlands [males (top) and females (bottom)] United Kingdom [males (top) and females (bottom)] 
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Greece [males (top) and females (bottom)] Ireland [males (top) and females (bottom)] 
average adj. Gini adj. CI average adj. Gini adj. CI 
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Italy [males (top) and females (bottom)] Portugal [males (top) and females (bottom)] 
average adj. Gini adj. CI average adj. Gini adj. CI 
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Table 1: Average ages of the three youngest cohorts across the panel 
 
Cohort 1 20     21     22     23     24 25     26     27  
Cohort 2  25     26     27     28     29 30     31     32 
Cohort 3   30     31     32     33     34 
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Table A.1: Descriptive Statistics  
 FRA GER NL UK GR ITA POR SPA BE DK IRE 
Observations Wave 1 13166 11829 9048 7809 11859 16657 10936 16883 6427 5652 9472 
Observations Wave 2 11623 11041 8140 6841 10506 15488 10208 14006 5749 4919 7572 
Observations Wave 3 11039 10518 7786 6618 9640 14967 9671 13066 5316 4385 6405 
Observations Wave 4 9926 10053 7347 6359 8877 13672 9281 11754 4812 3956 5678 
Observations Wave 5 9156 9413 6769 6105 8837 14239 10019 11835 4809 3851 5462 
Observations Wave 6 8523 8948 6200 5550 8331 13553 9762 11198 4443 3623 4621 
Observations Wave 7 7902 8480 5731 5287 8104 12692 9461 10424 4150 3425 3720 
Observations Wave 8 7601 8070 5106 5021 8012 11516 9237  10044 3736 3368 3248 
Mean SAH1 2.41 2.66 2.16 2.19 1.91 2.38 2.81 2.34 2.13 1.86 1.79 
Mean HUI32 0.87 0.84 0.90 0.88 0.89 0.87 0.83 0.87 0.89 0.90 0.91 
Mean income3 184928 57515 55377 19841 4295866 39169 2339057 2876558 1224194 249015 21579 
Mean age 47.55 46.16 47.43 47.31 49.54 46.30 49.11 47.66 47.35 46.86 46.15 
Proportion of males 0.47 0.48 0.47 0.47 0.47 0.49 0.48 0.48 0.47 0.49 0.49 
Notes:  
1. Self Assessed Health on five-point scale with ‘very bad’ given a value of 1 and ‘very good’ a value of 5. 
2. Health Utility Index Mark 3. 
3. National currency units. 
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Table A.2: Joint significance tests (p-values) per statistic of the age and cohort dummies separately for males (left) and females (right) 
Country Age/Cohort Mean Adj. Gini Adj. CI Mean Adj. Gini Adj. CI 
France Age 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
 Cohort 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
Germany Age 0.0000 0.0000 0.0665 0.0000 0.0000 0.0000 
 Cohort 0.0001 0.0009 0.0000 0.0000 0.0005 0.0000 
Netherlands Age 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
 Cohort 0.0000 0.0000 0.0011 0.0000 0.0000 0.0000 
UK Age 0.0000 0.0000 0.0002 0.0000 0.0000 0.0000 
 Cohort 0.0000 0.0000 0.0115 0.0000 0.0000 0.0000 
Greece Age 0.0000 0.0000 0.0001 0.0000 0.0000 0.0000 
 Cohort 0.0000 0.0000 0.0028 0.0000 0.0000 0.5484 
Italy Age 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
 Cohort 0.0000 0.0000 0.0000 0.0000 0.0000 0.0012 
Portugal Age 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
 Cohort 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
Spain Age 0.0000 0.0000 0.0483 0.0000 0.0000 0.0150 
 Cohort 0.0000 0.0000 0.0000 0.0000 0.0000 0.0863 
Belgium Age 0.0000 0.0000 0.0229 0.0000 0.0000 0.0000 
 Cohort 0.0000 0.0001 0.0000 0.0000 0.0000 0.0000 
Denmark Age 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
 Cohort 0.0006 0.0000 0.0031 0.0000 0.0000 0.0074 
Ireland Age 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
 Cohort 0.0000 0.0000 0.0022 0.0000 0.0000 0.0000 
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Notes 
                                                 
1 Deaton and Paxson (1998) propose that the evolution of health is given by 1it it ith h u−= + (Deaton and Paxson, 
1994). Assuming zero covariance between lagged health and the health shock (u), ( ) ( ) 21var var 0t t uh h σ−− = > if 
health shocks are not perfectly correlated across individuals. But if health evolves according to a depreciation 
process, ( )1 1it it ith h δ−= − , where [ )0,1itδ ∈  represents the stochastic rate of depreciation that is assumed 
independent of the level of health, then ( ) ( ) ( ) ( ) ( ) ( )( )22 2 2, 1 , 1 , 1 , 1
1 2
var var 2 varit i t t i t i t it i t t
term term
h h h E h E E hδ δ δ− − − −− = − + −1442443 14444424444443  
(Goodman, 1960). Term 1 in the latter equation is negative, while term 2 is positive; which is larger depends 
upon the distribution of itδ . For example, if the depreciation rate is a constant, then the variance will be 
decreasing over time (Deaton and Paxson, 1994). 
2 Burström et al. (2005) do report that inequalities in life expectancy and QALYs have been increasing over 
time. Pappas et al. (1993) also find increasing socioeconomic inequalities in mortality in the US. 
3 The BHPS only covers Great Britain, but for convenience we refer to the UK throughout the text. 
4 The OECD scale gives a weight of 1.0 to the first adult, 0.5 to the second and each subsequent person aged 14 
and over, and 0.3 to each child aged under 14 in the household. 
5 The SAH question in France and Germany was consistent with the other ECHP countries but a 6 and 10 point 
scale respectively was used and responses were recoded into the common 5 point scale by Eurostat. 
6 The adjusted concentration index is defined as ( ) ( )4 i i
h h
E h
CI h
b a−  where ( )iCI h  is the standard concentration 
index (Wagstaff et al., 1991), and hb  and ha  are the maximum and minimum of the health variable ih . 
7 Define , 0, 0i ih c dh c d= + > >% , then, of course, ( ) ( )i iE h c dE h= +% . The value of mean health depends on the 
values of c  and d , but its life cycle profile, represented by the difference in mean health between age groups, is 
invariant up to multiplication by the scalar d. The latter does not hold for the standard concentration and Gini 
indices (Wagstaff et al., 1991) since ( ) ( )( ) ( ) ( )ii i ii
dE h
CI h CI h c dCI h
c dE h
= ≠ ++
% . For the adjusted concentration 
and Gini indices (Erreygers, 2006, 2008) we have an even stronger result since their values are independent 
from c  and d , i.e. ( ) ( ) ( ) ( ) ( ) ( ) ( )( ) ( ) ( )
4 44 4i i ii i i i i i
h h h h i h hh h
E h CI h c dE hE c dh CI c dh dE h CI h E h CI h
c db c da db da c dE h b ab a
+⎡ ⎤+ + ⎣ ⎦= = =+ − − − + −−
% %
% % . 
8 The income measure in the CCHS is not continuous, but in six categories. We neglect its ordinal nature while 
calculating the adjusted concentration index since our purpose is simply to illustrate the advantage of using SAH 
category, age-sex specific means of HUI3. 
9 For the mean, the age profile drawn from the SAH category, age-sex specific means of HUI3 is necessarily 
identical to that drawn from the observation specific HUI3 scores. 
10 More precisely, dummies are defined as follows: dummy1 (age=20), dummy2 (age=21,22), dummy3 
(age=23,24), dummy4 (age=25), dummy5 (age=26,27), etc. Note that these age dummies only cover the average 
age of the cohort in a particular wave. So there is no dummy for ages 18-19. For the UK this structure is not 
suitable since the dummies do not correctly embed the overlap in ages between five year birth cohorts given that 
one wave of the panel is omitted. We therefore used six year birth cohorts and a combination of 1, 2 and 3 year 
age dummies for the UK. This ensures an overlap of three years for consecutive cohorts, as for the other 
countries. 
11 Observations that join the panel after the first wave are excluded because their inclusion would be inconsistent 
with the cohort nature of the analysis and it would render the method, described below, of correcting for attrition 
infeasible. 
12 Since the dependent variables are constructed for cohorts of individuals of different sizes, we use robust 
standard errors to correct for the resulting heteroskedasticity, if any. 
13 For males, only Denmark, Italy, Portugal and the UK have significant period effects for the mean. Only Spain 
has significant period effects for the adjusted Gini index. The effects for the adjusted concentration index are 
significant for British, German, and Portuguese males. For females, significance of the period effects is found 
for Denmark, France, Germany, Greece, Italy, Portugal, Spain and UK for the mean. For the Gini index 
German, Greek, Italian, and Spanish females have significant period effects. Finally, for the concentration index 
only German females have significant period effects. 
